The Rising Impact of Immunotherapy in Advanced NSCLC
Lung cancer remains one of the leading causes of cancer-related deaths around the globe. Among its various forms, non-small cell lung cancer (NSCLC) is by far the most common, making up about 80–85% of all lung cancer diagnoses. When it reaches an advanced stage—often referred to as Stage IV or metastatic NSCLC—the cancer has spread […]
The Rising Impact of Immunotherapy in Advanced NSCLC Read More »
